论文部分内容阅读
目的探讨茵桅黄颗粒联合双歧杆菌三联活菌胶囊治疗新生儿黄疸的临床疗效。方法将我院门诊2008年5月到2010年6月的新生儿黄疸120例,随机分为对照组与观察组,每组60例。对照组给予妈咪爱散口服,观察组给予茵桅黄、双歧杆菌三联活菌口服,观察两组患儿治疗前后皮肤巩膜黄疸情况及经皮测胆红素值变化。结果治疗后7天临床有效率分别为68.3%和93.3%(P<0.01)。治疗组治疗后黄疸程度及经皮测胆红素值明显下降,差异显著。结论茵桅黄联合山歧三联活菌治疗新生儿黄疸,可较快地改善临床症状,降低血清胆红素,预防并发症的发生率,而且不用打针,服用方便、副作用小,值得临床推广和应用。
Objective To investigate the clinical efficacy of ominfied yellow granules combined with bifidobacterium triple viable capsule in the treatment of neonatal jaundice. Methods 120 cases of neonatal jaundice in our hospital from May 2008 to June 2010 were randomly divided into control group and observation group, with 60 cases in each group. The control group was given Mommy Ai San, the observation group was given Yinhuang yellow, oral live Bifidobacterium triple viable, the two groups of children with scleral jaundice before and after treatment and percutaneous bilirubin value changes. Results The clinical effective rates at 7 days after treatment were 68.3% and 93.3%, respectively (P <0.01). After treatment, the degree of jaundice and percutaneous bilirubin in treatment group decreased significantly, with significant difference. Conclusion Yin Mulai combined Shanhaizhu triple viable bacteria treatment of neonatal jaundice, can improve clinical symptoms faster, lower serum bilirubin, prevent the incidence of complications, and without injection, easy to take, side effects, worthy of clinical promotion and application.